Skip to main content
Get 20% OFF your first order

Pearlcam May 2026

Before a new cancer drug or imaging agent can be tested on humans, it must be proven effective and safe in animal models. Systems like the LI-COR Pearl Trilogy provide the high-quality data required by regulatory bodies (like the FDA) to move a discovery from the lab to the clinic.

Biological tissues naturally glow under certain light; the NIR range used by PearlCAM minimizes this "noise," resulting in much clearer images. PearlCAM

💡 Many researchers prefer the Pearl system because it uses a One-Touch imaging approach—eliminating the need for complex camera adjustments and making the technology accessible even to those without a background in physics. Before a new cancer drug or imaging agent

The subject is placed in the imaging chamber. PearlCAM software captures the NIR signal and overlays it on a standard grayscale "white light" image for anatomical context. 💡 Many researchers prefer the Pearl system because

Capabilities typically include 700 nm and 800 nm channels, allowing researchers to track two different biological markers simultaneously. 📈 Key Applications in Research

Because the imaging is non-invasive, researchers can scan the same animal over days or weeks. This reduces the number of animals needed for a study and provides a more accurate timeline of how a tumor grows or shrinks in response to treatment. 🛠 Features and Workflow

Researchers use PearlCAM to test new "smart" dyes that attach specifically to cancer cells. By viewing the animal through the Pearl system, surgeons can practice identifying tumor margins that would be invisible to the naked eye. Washington University has utilized this for foundations in translational imaging. 2. Drug Delivery Tracking